Opinion | Getting a gonorrhea antibiotic to regulators is remarkable - The Washington Post
washingtonpost.comSubmitted by thewashingtonpost7104 in news
Funding clinical trials with public and philanthropic money could fix market failure as treatable infections become untreatable.